Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOTEGRAVIR vs CABOZANTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABOTEGRAVIR vs CABOZANTINIB: Safety Overview

Metric CABOTEGRAVIR CABOZANTINIB
Total FAERS Reports 8,304 3,831
Deaths Reported 144 767
Death Rate 1.7% 20.0%
Hospitalizations 428 2,771
Average Patient Age 41.7 yrs 62.2 yrs
% Female Patients 22.1% 27.5%
FDA Approval Date Dec 20, 2021 N/A
Manufacturer ViiV Healthcare Company N/A
Route ORAL N/A
Marketing Status Prescription None